Meihua International Medical Technologies Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG5966G1082
USD
14.02
1.47 (11.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

9.33 k

Shareholding (Dec 2024)

FII

0.22%

Held by 3 FIIs

DII

99.62%

Held by 0 DIIs

Promoter

0.00%

How big is Meihua International Medical Technologies Co., Ltd.?

22-Jun-2025

As of Jun 18, Meihua International Medical Technologies Co., Ltd. has a market capitalization of 12.06 million, with net sales of 73.58 million and a consolidated net profit of 28.67 million over the latest four quarters.

Market Cap: As of Jun 18, Meihua International Medical Technologies Co., Ltd. has a market capitalization of 12.06 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported net sales of 73.58 million and a consolidated net profit of 28.67 million.<BR><BR>Balance Sheet Snapshot: As of December 2024, the company has shareholder's funds amounting to 158.98 million and total assets of 186.24 million.

Read More

What does Meihua International Medical Technologies Co., Ltd. do?

22-Jun-2025

Meihua International Medical Technologies Co., Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $21 million and a net profit of $8 million as of June 2023. Key metrics include a P/E ratio of 1.00 and a market cap of $12.06 million.

Overview: <BR>Meihua International Medical Technologies Co., Ltd. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Sales: 21 Million (Quarterly Results - Jun 2023) <BR>Net Profit: 8 Million (Quarterly Results - Jun 2023) <BR>Market cap: USD 12.06 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 1.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.06 <BR>Return on Equity: 18.04% <BR>Price to Book: 0.08 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is Meihua International Medical Technologies Co., Ltd. technically bullish or bearish?

20-Sep-2025

As of September 9, 2025, Meihua International Medical Technologies Co., Ltd. shows a mildly bullish trend overall, with mixed signals from various technical indicators across different time frames.

As of 9 September 2025, the technical trend for Meihua International Medical Technologies Co., Ltd. has changed from mildly bearish to mildly bullish. The MACD indicates a mildly bullish stance on both weekly and monthly time frames, while the moving averages are bullish on a daily basis. However, the KST shows a mildly bearish trend on the weekly and bearish on the monthly, and Bollinger Bands are sideways on the weekly and mildly bearish on the monthly. The Dow Theory suggests a mildly bullish trend on the monthly, but no trend on the weekly. Overall, the indicators present a mildly bullish stance, though mixed signals exist across different metrics. Multi-period return data is not available for comparison with the S&P 500.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 12 Million ()

stock-summary
P/E

1.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.06

stock-summary
Return on Equity

18.04%

stock-summary
Price to Book

0.08

Revenue and Profits:
Net Sales:
21 Million
(Quarterly Results - Jun 2023)
Net Profit:
8 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-62.11%
0%
-62.11%
6 Months
-77.2%
0%
-77.2%
1 Year
-69.61%
0%
-69.61%
2 Years
-91.24%
0%
-91.24%
3 Years
-98.57%
0%
-98.57%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Meihua International Medical Technologies Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
136.88%
EBIT Growth (5y)
17.92%
EBIT to Interest (avg)
9.90
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
0.43
Tax Ratio
27.14%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.03%
ROCE (avg)
26.27%
ROE (avg)
20.65%
Valuation key factors
Factor
Value
P/E Ratio
1
Industry P/E
Price to Book Value
0.12
EV to EBIT
0.29
EV to EBITDA
0.29
EV to Capital Employed
0.07
EV to Sales
0.13
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
22.51%
ROE (Latest)
18.04%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Bearish
Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 2 Schemes (0.15%)

Foreign Institutions

Held by 3 Foreign Institutions (0.22%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'23 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2023 is 61.42% vs 16.51% in Jun 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2023 is 26.23% vs 35.56% in Jun 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'23",
        "Jun'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "20.50",
          "val2": "12.70",
          "chgp": "61.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.70",
          "val2": "4.80",
          "chgp": "81.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.50",
          "val2": "0.60",
          "chgp": "483.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.70",
          "val2": "6.10",
          "chgp": "26.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -6.00% vs -0.67% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 87.10% vs -70.33% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "97.10",
          "val2": "103.30",
          "chgp": "-6.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.10",
          "val2": "11.40",
          "chgp": "32.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.20",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11.60",
          "val2": "6.20",
          "chgp": "87.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "151.10%",
          "val2": "104.50%",
          "chgp": "4.66%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'23 - YoYstock-summary
Jun'23
Jun'22
Change(%)
Net Sales
20.50
12.70
61.42%
Operating Profit (PBDIT) excl Other Income
8.70
4.80
81.25%
Interest
3.50
0.60
483.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
7.70
6.10
26.23%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2023 is 61.42% vs 16.51% in Jun 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2023 is 26.23% vs 35.56% in Jun 2022

Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
97.10
103.30
-6.00%
Operating Profit (PBDIT) excl Other Income
15.10
11.40
32.46%
Interest
0.30
0.20
50.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
11.60
6.20
87.10%
Operating Profit Margin (Excl OI)
151.10%
104.50%
4.66%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -6.00% vs -0.67% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 87.10% vs -70.33% in Dec 2022

stock-summaryCompany CV
About Meihua International Medical Technologies Co., Ltd. stock-summary
stock-summary
Meihua International Medical Technologies Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available